INOZYME PHARMA, INC. Financing Cash Flow
INOZYME PHARMA, INC. reported Financing Cash Flow of $228.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2025-05-14
- INOZYME PHARMA, INC. net cash provided by (used in) financing activities for the quarter ending 2025-03-31 was $228.00K, a 43.40% increase year-over-year.
- INOZYME PHARMA, INC. net cash provided by (used in) financing activities for the quarter ending 2024-12-31 was $258.00K, a 97.94% decline year-over-year.
- INOZYME PHARMA, INC. net cash provided by (used in) financing activities for the quarter ending 2024-09-30 was $10.52M, a 84.91% decline year-over-year.
- INOZYME PHARMA, INC. net cash provided by (used in) financing activities for the quarter ending 2024-06-30 was $458.00K, a 98.06% decline year-over-year.
- INOZYME PHARMA, INC. net cash provided by (used in) financing activities for fiscal 2024 was $11.40M, a 90.95% decline from fiscal 2023.
- INOZYME PHARMA, INC. net cash provided by (used in) financing activities for fiscal 2023 was $125.97M, a 73.06% increase from fiscal 2022.
- INOZYME PHARMA, INC. net cash provided by (used in) financing activities for fiscal 2022 was $72.79M, a 11852.05% increase from fiscal 2021.
- INOZYME PHARMA, INC. net cash provided by (used in) financing activities for fiscal 2021 was $609.00K, a 99.59% decline from fiscal 2020.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2025-03-31 | $228.00K 10-Q · filed 2025-05-14 | $486.00K derived: sum of 2 quarters · filed 2025-05-14 | $11.01M derived: sum of 3 quarters · filed 2025-05-14 | $11.47M derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-12-31 | $258.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $10.78M derived: sum of 2 quarters · filed 2025-03-10 | $11.24M derived: sum of 3 quarters · filed 2025-03-10 | $11.40M 10-K · filed 2025-03-10 |
| 2024-09-30 | $10.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $10.98M derived: sum of 2 quarters · filed 2024-11-05 | $11.14M 10-Q · filed 2024-11-05 | $23.66M derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-06-30 | $458.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $617.00K 10-Q · filed 2024-08-06 | $13.13M derived: sum of 3 quarters · filed 2025-05-14 | $82.85M derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-03-31 | $159.00K 10-Q · filed 2025-05-14 | $12.68M derived: sum of 2 quarters · filed 2025-05-14 | $82.39M derived: sum of 3 quarters · filed 2025-05-14 | $106.03M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $12.52M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $82.23M derived: sum of 2 quarters · filed 2025-03-10 | $105.87M derived: sum of 3 quarters · filed 2025-03-10 | $125.97M 10-K · filed 2025-03-10 |
| 2023-09-30 | $69.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $93.36M derived: sum of 2 quarters · filed 2024-11-05 | $113.45M 10-Q · filed 2024-11-05 | $113.45M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | $23.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $43.74M 10-Q · filed 2024-08-06 | $43.74M derived: sum of 3 quarters · filed 2024-08-06 | $47.95M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $20.10M 10-Q · filed 2024-05-07 | $20.10M derived: sum of 2 quarters · filed 2024-05-07 | $24.31M derived: sum of 3 quarters · filed 2024-05-07 | $92.64M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $4.21M derived: sum of 2 quarters · filed 2024-03-12 | $72.55M derived: sum of 3 quarters · filed 2024-03-12 | $72.79M 10-K · filed 2024-03-12 |
| 2022-09-30 | $4.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $72.55M derived: sum of 2 quarters · filed 2023-11-07 | $72.79M 10-Q · filed 2023-11-07 | $72.80M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $68.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $68.57M 10-Q · filed 2023-08-08 | $68.58M derived: sum of 3 quarters · filed 2023-08-08 | $68.82M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $240.00K 10-Q · filed 2023-05-09 | $251.00K derived: sum of 2 quarters · filed 2023-05-09 | $488.00K derived: sum of 3 quarters · filed 2023-05-09 | $600.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $248.00K derived: sum of 2 quarters · filed 2023-03-22 | $360.00K derived: sum of 3 quarters · filed 2023-03-22 | $609.00K 10-K · filed 2023-03-22 |
| 2021-09-30 | $237.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $349.00K derived: sum of 2 quarters · filed 2022-11-10 | $598.00K 10-Q · filed 2022-11-10 | -$388.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $112.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $361.00K 10-Q · filed 2022-08-15 | -$625.00K derived: sum of 3 quarters · filed 2022-08-15 | $118.24M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $249.00K 10-Q · filed 2022-05-10 | -$737.00K derived: sum of 2 quarters · filed 2022-05-10 | $118.12M derived: sum of 3 quarters · filed 2022-05-10 | $150.06M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | -$986.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $117.88M derived: sum of 2 quarters · filed 2022-03-15 | $149.81M derived: sum of 3 quarters · filed 2022-03-15 | $149.81M 10-K · filed 2022-03-15 |
| 2020-09-30 | $118.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $150.79M derived: sum of 2 quarters · filed 2021-11-09 | $150.80M 10-Q · filed 2021-11-09 | $150.81M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $31.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $31.94M 10-Q · filed 2021-08-11 | $31.95M derived: sum of 3 quarters · filed 2021-08-11 | $31.98M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $5.00K 10-Q · filed 2021-05-12 | $14.00K derived: sum of 2 quarters · filed 2021-05-12 | $43.00K derived: sum of 3 quarters · filed 2021-05-12 | |
| 2019-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $38.00K derived: sum of 2 quarters · filed 2021-03-25 | $22.97M 10-K · filed 2021-03-25 | |
| 2019-09-30 | $29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $22.96M 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | $22.93M 10-Q · filed 2020-09-03 |